Coeptis Therapeutics Stock Analysis

Coeptis Stock Analysis Notes

About 19.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.47. Coeptis Therapeutics last dividend was issued on the 6th of August 2020. The entity had 1:40000 split on the 6th of August 2020. Coeptis Therapeutics Holdings, Inc., a biopharmaceutical company, develops and commercializes generic and branded pharmaceutical products and cell therapy platforms for patients with cancer. Coeptis Therapeutics Holdings, Inc. was founded in 2017 and is headquartered in Wexford, Pennsylvania. Coeptis Therapeutics is traded on NASDAQ Exchange in the United States. For more info on Coeptis Therapeutics please contact the company at 724 934 6467 or go to https://coeptistx.com.

Coeptis Therapeutics Investment Alerts

Coeptis Therapeutics Upcoming and Recent Events

Coeptis Largest EPS Surprises

View All Earnings Estimates

Coeptis Therapeutics Environmental, Social, and Governance (ESG) Scores

Coeptis Stock Institutional Investors

Note, although Coeptis Therapeutics' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Coeptis Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 8.06 M.

Coeptis Profitablity

Management Efficiency

Coeptis Therapeutics has return on total asset (ROA) of (1.8735) % which means that it has lost $1.8735 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (14.8129) %, meaning that it created substantial loss on money invested by shareholders. Coeptis Therapeutics' management efficiency ratios could be used to measure how well Coeptis Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. As of 03/16/2025, Return On Tangible Assets is likely to grow to -11.52. In addition to that, Return On Capital Employed is likely to grow to -14.84. As of 03/16/2025, Non Current Liabilities Total is likely to grow to about 1.1 M, while Total Current Liabilities is likely to drop slightly above 2.3 M.

Technical Drivers

As of the 16th of March 2025, Coeptis Therapeutics shows the mean deviation of 8.03, and Risk Adjusted Performance of 0.1635. Coeptis Therapeutics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Coeptis Therapeutics Price Movement Analysis

Coeptis Therapeutics Insider Trading Activities

Coeptis Therapeutics Outstanding Bonds

Coeptis Therapeutics Predictive Daily Indicators

Coeptis Therapeutics Corporate Filings

Coeptis Therapeutics Forecast Models

Coeptis Therapeutics' time-series forecasting models are one of many Coeptis Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Coeptis Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Coeptis Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Coeptis shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Coeptis Therapeutics. By using and applying Coeptis Stock analysis, traders can create a robust methodology for identifying Coeptis entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Coeptis analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Coeptis analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Coeptis Therapeutics stock analysis indicators help investors evaluate how Coeptis Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Coeptis Therapeutics shares will generate the highest return on investment. By understating and applying Coeptis Therapeutics stock analysis, traders can identify Coeptis Therapeutics position entry and exit signals to maximize returns.

When running Coeptis Therapeutics' price analysis, check to measure Coeptis Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Coeptis Therapeutics is operating at the current time. Most of Coeptis Therapeutics' value examination focuses on studying past and present price action to predict the probability of Coeptis Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Coeptis Therapeutics' price. Additionally, you may evaluate how the addition of Coeptis Therapeutics to your portfolios can decrease your overall portfolio volatility.